AU2001261606A1 - Method for treating functional dyspepsia - Google Patents

Method for treating functional dyspepsia

Info

Publication number
AU2001261606A1
AU2001261606A1 AU2001261606A AU6160601A AU2001261606A1 AU 2001261606 A1 AU2001261606 A1 AU 2001261606A1 AU 2001261606 A AU2001261606 A AU 2001261606A AU 6160601 A AU6160601 A AU 6160601A AU 2001261606 A1 AU2001261606 A1 AU 2001261606A1
Authority
AU
Australia
Prior art keywords
functional dyspepsia
treating functional
treating
dyspepsia
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261606A
Inventor
Allen Wayne Mangel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001261606A1 publication Critical patent/AU2001261606A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
AU2001261606A 2000-05-18 2001-05-15 Method for treating functional dyspepsia Abandoned AU2001261606A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20530800P 2000-05-18 2000-05-18
US60205308 2000-05-18
PCT/US2001/015633 WO2001087305A2 (en) 2000-05-18 2001-05-15 Method for treating functional dyspepsia using alosetron

Publications (1)

Publication Number Publication Date
AU2001261606A1 true AU2001261606A1 (en) 2001-11-26

Family

ID=22761668

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261606A Abandoned AU2001261606A1 (en) 2000-05-18 2001-05-15 Method for treating functional dyspepsia

Country Status (4)

Country Link
EP (1) EP1284732A2 (en)
JP (1) JP2003533482A (en)
AU (1) AU2001261606A1 (en)
WO (1) WO2001087305A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003100091A1 (en) * 2002-05-24 2003-12-04 Epidauros Biotechnologie Ag Means and methods for improved treatment using 'setrones'
CA2560279A1 (en) * 2004-03-19 2005-09-29 Solvay Pharmaceuticals Gmbh Use of a 5-ht3 receptor antagonist for the manufacture of a medicament for the treatment of non-digestive tract derived abdominal disorders associated with pain
US7820690B2 (en) 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96486A (en) * 1989-11-28 1995-03-30 Syntex Inc Tricyclic compounds, their preparation and pharmaceutical compositions containing them
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
US5192770A (en) * 1990-12-07 1993-03-09 Syntex (U.S.A.) Inc. Serotonergic alpha-oxoacetamides
US5516782A (en) * 1991-03-07 1996-05-14 G. D. Searle & Co. New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
TWI263496B (en) * 1999-12-10 2006-10-11 Novartis Ag Pharmaceutical combinations and their use in treating gastrointestinal disorders
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
JP2003533482A (en) 2003-11-11
WO2001087305A3 (en) 2002-04-25
EP1284732A2 (en) 2003-02-26
WO2001087305A2 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU2002215125A1 (en) Well treatment method
AU2001231104A1 (en) Methods for treating diabetes
AU1484202A (en) Method for treating films
AU2651701A (en) Method for introducing additives
AU2001238369A1 (en) Method for treating thyroid disorders
AU2001245283A1 (en) Methods for treating aneurysms
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AU3222801A (en) Method for treating oil-containing sludge
AU2002213972A1 (en) Method for producing polyisobutenylphenoles
AU2001273609A1 (en) Process for treating wood
AU2001239243A1 (en) Method for producing nanosuspensions
AUPR152100A0 (en) Method for treating coral
AU2001277938A1 (en) Method for treating angina
AU2002241670A1 (en) Method for treating glaucoma IB
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001237530A1 (en) Method
GB0118883D0 (en) Method for treating objects
GB0123898D0 (en) Method for treating objects
IL145799A0 (en) Method for treating neurodegeneration
GB0122810D0 (en) Method for treating objects
GB0123897D0 (en) Method for treating objects
AU2001261606A1 (en) Method for treating functional dyspepsia
AU2001241636A1 (en) Halotherapy method
AU2001243297A1 (en) Method for treating or preventing depression
AU2002220757A1 (en) Method for obtaining azaerythromycin